“El País” newspaper has published an article on the Barcelona BioMed Conference “Drosophila as a model in cancer”. It includes statements made by Marco Milán, ICREA researcher and head of the Development and Growth Control Laboratory, and Cayetano González, ICREA researcher and head of the Cell Division Laboratory, both at IRB Barcelona and co-organizers of this scientific meeting, which is supported by the BBVA Foundation.
The article highlights the project presented by Ross Cagan, director of the Center for Personalized Cancer Therapeutics at Mount Sinai Hospital (United States), which uses flies that have the same tumours as those found in human patients to design personalized treatments for cancer.
Read the article in “El País” (in Spanish)
About IRB Barcelona
Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).